HEPATIC NEOPLASM MALIGNANT RECURRENT

This adverse event was reported 106 times

HEPATIC NEOPLASM MALIGNANT RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EQUINE THYMOCYTE IMMUNE GLOBULIN 3 0.0029
1 AMPICILLIN AND SULBACTAM 1 0.0011
2 ADEFOVIR DIPIVOXIL 1 0.0008
3 GANCICLOVIR SODIUM 6 0.0006
4 MITOMYCIN 2 0.0005
5 VINBLASTINE SULFATE 1 0.0005
6 ENTECAVIR 5 0.0004
7 AMPICILLIN SODIUM AND SULBACTAM SODIUM 1 0.0004
8 CLINDAMYCIN PHOSPHATE 2 0.0004
9 BASILIXIMAB 4 0.0003
See all drugs enriched for association with HEPATIC NEOPLASM MALIGNANT RECURRENT